Gene · 9475
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Manipulation of the crosstalk between tumor angiogenesis and immunosuppression in the tumor microenvironment: Insight into the combination therapy of anti-angiogenesis and immune checkpoint blockade. | Front Immunol | 2022 | 36439137 | PubTator, text mining | PubMed |
| The Effects of Different Doses of ROCK Inhibitor, Antifreeze Protein III, and Boron Added to Semen Extender on Semen Freezeability of Ankara Bucks. | Molecules | 2022 | 36432171 | PubTator, text mining | PubMed |
| Systems Drug Design for Muscle Invasive Bladder Cancer and Advanced Bladder Cancer by Genome-Wide Microarray Data and Deep Learning Method with Drug Design Specifications. | Int J Mol Sci | 2022 | 36430344 | PubTator, text mining | PubMed |
| 17-β Estradiol up-regulates energy metabolic pathways, cellular proliferation and tumor invasiveness in ER+ breast cancer spheroids. | Front Oncol | 2022 | 36419896 | PubTator, text mining | PubMed |
| Biological role of matrix stiffness in tumor growth and treatment. | J Transl Med | 2022 | 36419159 | PubTator, text mining | PubMed |
| Evaluation of the Rho-kinase gene expression and polymorphisms in adult patients with acute appendicitis: a differential impact of gender. | Rev Assoc Med Bras (1992) | 2022 | 36417654 | PubTator, text mining | PubMed |
| Changes in interstitial fluid flow, mass transport and the bone cell response in microgravity and normogravity. | Bone Res | 2022 | 36411278 | PubTator, text mining | PubMed |
| Rho family GTPase signaling through type II p21-activated kinases. | Cell Mol Life Sci | 2022 | 36401658 | PubTator, text mining | PubMed |
| Cervical cancer heterogeneity: a constant battle against viruses and drugs. | Biomark Res | 2022 | 36397138 | PubTator, text mining | PubMed |
| Dysregulation and chronicity of pathogenic T cell responses in the pre-diseased stage of lupus. | Front Immunol | 2022 | 36389689 | PubTator, text mining | PubMed |
| Drug discovery in China: A snapshot of recent progress. | Acta Pharm Sin B | 2022 | 36386469 | PubTator, text mining | PubMed |
| Construction of a 10-gene prognostic score model of predicting recurrence for laryngeal cancer. | Eur J Med Res | 2022 | 36376905 | PubTator, text mining | PubMed |
| Integrated analysis identified prognostic microRNAs in breast cancer. | BMC Cancer | 2022 | 36371182 | PubTator, text mining | PubMed |
| Collective genomic segments with differential pleiotropic patterns between cognitive dimensions and psychopathology. | Nat Commun | 2022 | 36369282 | PubTator, text mining | PubMed |
| Identification of Hypoxia-Related Prognostic Signature and Competing Endogenous RNA Regulatory Axes in Hepatocellular Carcinoma. | Int J Mol Sci | 2022 | 36362375 | PubTator, text mining | PubMed |
| Experimental Treatments for Spinal Cord Injury: A Systematic Review and Meta-Analysis. | Cells | 2022 | 36359804 | PubTator, text mining | PubMed |
| Inhibition of IκB Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer Cells. | Cancers (Basel) | 2022 | 36358633 | PubTator, text mining | PubMed |
| IGFBP1hiWNT3Alo Subtype in Esophageal Cancer Predicts Response and Prolonged Survival with PD-(L)1 Inhibitor. | Biology (Basel) | 2022 | 36358276 | PubTator, text mining | PubMed |
| Regulation of autophagy by non-coding RNAs in gastric cancer. | Front Oncol | 2022 | 36353541 | PubTator, text mining | PubMed |
| Role of protein phosphorylation in cell signaling, disease, and the intervention therapy. | MedComm (2020) | 2022 | 36349142 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9475/papers?page=35